They proposed that ICC can be classified into S100P + SPP1− and S100P−SPP1+ ICC subtypes based on S100P and SPP1 expression and noted significant differences in clinicopathological characteristics, gene regulatory networks, and immune infiltration between these two ICC subtypes. This evidence concerns the gene SPP1 and intrahepatic cholangiocarcinoma.